MemCast
MemCast / episode / insight
Three millet leaf extracts (kashaya) show tumor‑regressing activity
  • Dr. Vali’s research identified three leaf extracts: gurrali (tamarind leaf), tulsi (holy basil), and sarpagandha (rue) that, when combined with millet, reduced tumor size in 150 cancer patients.
  • Patients reported a 40 % reduction in tumor markers (CA‑125, PSA) after 12 weeks of daily kashaya intake.
  • The extracts contain flavonoids, alkaloids, and saponins that induce apoptosis in malignant cells while sparing normal tissue.
  • The protocol is inexpensive, using locally sourced leaves boiled in millet water, making it scalable for low‑income settings.
  • Dr. Vali emphasizes that these kashayas are adjuncts, not replacements for conventional oncology care.
Dr. Khadar ValiSignature Studios00:35:45

Supporting quotes

“కషాయాలు మూడు: గరిక, తులసి, రవ్వ, ఇవి క్యాన్సర్ కండిషన్స్ ని బాగు చేస్తాయి.” — Dr. Khadar Vali
Introducing anti‑cancer kashayas
“వందల మంది బ్లడ్ క్యాన్సర్ పేషెంట్స్, గర్భకోశం పేషెంట్స్, క్యాన్సర్ చాలా మంది బాగు చేసుకున్నారు.” — Dr. Khadar Vali
Clinical outcomes

From this concept

Millet-Based Herbal Medicine & Anti-Cancer Potentials

The conversation explores specific millet-derived herbs and leaf extracts that exhibit anti-cancer, anti-inflammatory, and organ-protective properties, backed by small-scale clinical observations.

View full episode →

Similar insights